Navigation Links
A National Survey Revealed That Mental Disorders Are Common In Lebanon

Even though mental disorders are said to account for a large portion of disease burden worldwide, no national studies have been undertaken to assess// this assumption in the Arab world.

To overcome this and as part of the WHO World Mental Health (WMH) Survey Initiative, a nationally representative psychiatric epidemiological survey of 2857 adults was done in Lebanon between September, 2002, and September, 2003, through a study called LEBANON (Lebanese Evaluation of the Burden of Ailments and Needs Of the Nation). Twelve month prevalence and severity of DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, fourth edition) disorders, and treatment were assessed with the WHO Composite International Diagnostic Interview. Information was also obtained for sociodemographics and exposure to traumatic events in the Lebanon wars.

308 (17·0%) of respondents met criteria for at least one 12-month DSM-IV/CIDI disorder, 108 (27·0%) of whom were classified serious and an additional 112 (36·0%) moderate. Nearly half of respondents had a history of exposure to war-related traumatic events. Significantly elevated odds ratios (OR) of mood, anxiety, and impulse-control disorders were associated with two (OR 2·0–3·6) or more (2·2–9·1) war-related traumatic events, resulting in substantially higher proportions of moderate and severe 12-month mental disorders in respondents exposed to multiple war-related traumata (16·8–20·4%) compared with other respondents (3·3–3·5%). Only 47 (10·9%) respondents with 12-month disorders obtained treatment. 85% of people were treated in the general medical sector and the mental-health-care system, and the rest by religious or spiritual advisers, counsellors, herbalists, or fortune-tellers.

In conclusion it has been found that mental disorders are common in Lebanon, with prevalence equivalent to that in Western Europe. However, the number of individuals with mental disorders who are not receiving treatment is conside
'"/>




Page: 1 2

Related medicine news :

1. National Lung Study in the process
2. Indian Nationals with Foreign Medical Degrees can now practice in India
3. Hepatitis B Vaccine To Be Included In National Immunization Programme
4. UK Govt Says On Course For National Chlamydia Screening
5. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
6. India extends National TB Control Program
7. President and Founder of National Obesity Forum Resigns
8. Hwang Woo Suk Suspended By Seoul National University
9. Indian National in Saudi Jail will be released soon
10. National Women and Girls HIV/AIDS Awareness Day
11. Calcutta National Medical College Strike Continues Unabated
Post Your Comments:
(Date:10/10/2008)... PHILADELPHIA, Oct. 10 /PRNewswire/ -- The Mobil...), a leading provider of on-site seated massage,se...l events, and special,affairs, announced today tha...ern Pennsylvania and the greater Philadelphia metr... increasing interest in our on-site,seated, massa...
(Date:10/10/2008)... BALTIMORE, Oct. 10 /PRNewswire/ -- A nationally...reatment strategies for patients with breast,cance...east Cancer,Strategies: From Biomarkers to Treatme...ess Month., It is challenging for practicing onco... to stay up to date on the latest patient care,adv...
(Date:10/9/2008)... ROYAL PALM BEACH, Fla., Oct. 9 /PRNewswire/ -- ...ly cutting-edge reality. Internationally,acclaimed...rst U.S. doctor,licensed to provide TA-65 to the p...Palm Beach, Florida., This is a revolutionary tec...es are part of your DNA. They are located at the e...
(Date:10/9/2008)... Offering Healthy Rewards and Educational Opportun... Front Line, PHILADELPHIA, Oct. 9 /PRNewswire/ ...k, Independence Blue Cross (IBC) honors its more t...y rewarding them with fun,healthy activities this...ncement training., Fielding more than 4 million i...
Breaking Medicine News(10 mins):Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2Health News:Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging 2Health News:Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging 3Health News:Independence Blue Cross Celebrates Customer Service Week 2
...-waste has resulted in the release of toxic chemic...eas of recycling yards yielding reason for concern...ing is that toxic chemicals are released during ea...cess into the workplace and in many cases into the...
...veloping inflammatory disorders like rheumatoid ar...oured fruits and vegetables like oranges, carrots ...ryptoxanthin, both of which are found in brightly-...t as antioxidants, and protect the body against th...
...im that a new protein identified can help in the t...betes. The protein has already shown promising res...es // and is known to keep blood sugar under contr...d that mice with an excess of the protein Sirt1 in...
...om Mayo Clinic had developed focused ultrasound to...tal for treating women suffering from uterinefibro...ce in treating this common condition that affects ..., because it is the first completely noninvasive t...
Other Medicine News:Health News:Outpatient Treatment Possible For Patients with Uterine Fibroid Tumors 2
(Date:10/9/2008)... Campaign to Spread Awareness and Bring Hope to Mi...RNewswire-USNewswire/ -- 133 million children,acro...es such as natural,disaster, civil war, and diseas...ing World Orphan Week by calling attention to the ...ia News Release, go to:, http://www.prnewswire.c...
(Date:10/9/2008)...ober 9 /- Diamyd Medical re...urnal, the New England Journal,of Medicine, has pu... study,of the Diamyd(R) diabetes vaccine for type ...in/prnh/20080314/297194 ), The article is now av...m.org ) and will be in print on October 30. It pre...
(Date:10/8/2008)...b Program to be Discontinued and Headcount to be R...ts Portfolio Review; Zanolimumab Program to be Di...of Employees, COPEN...A/S (OMX: GEN),announced today that it is disconti...n addition, as a result of a portfolio review and,...
(Date:10/8/2008)... study shows clinical improvement in patients with... Current treatment options have limited benefit fo...incurable blood vessel disease, -- Imatinib mes...rtain cancers, known to inhibit protein assoc...potential of imatinib mesylate in PAH in 2009...
Breaking Medicine Technology:Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non Hodgkins Lymphoma 836 1Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non Hodgkins Lymphoma 836 2Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non Hodgkins Lymphoma 836 3Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non Hodgkins Lymphoma 836 4Researchers take first steps towards spinal cord reconstruction following injury 1193 1Researchers take first steps towards spinal cord reconstruction following injury 1193 2Don Messer Will Speak in Upper Room Chapel to Observe World AIDS Day 6133 1Don Messer Will Speak in Upper Room Chapel to Observe World AIDS Day 6133 2Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 1Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 2Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 3Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 4Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 5Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 6Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 7Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 8Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 9Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 10Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 11Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 12Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 13
... Data Presented at the , 2007 American Society of ...n(R) Activity in Older Patients with AML and in,Re...ation of the molecular interaction of Aloxi(R),wit... Survival Analysis of Glioblastoma Patients,Treate...Described-- , --Survival Analysis of Irofulven in ...
...was well-tolerated with signs of durable,disease c...lif., June 05, 2007 /PRNewswire-FirstCall/ -- IDM,...rom a Phase II,UVIDEM (IDD-3) melanoma vaccine cli...UVIDEM was well tolerated with evidence of,efficac...h,progressive metastatic melanoma. , The data were...
Other Medicine Technology:MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 2IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 3IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 4IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 5
Sealing Mat for 96-well PCR Plate, Natural
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times.
Omniseal TD mat. Reusable rubber mat for sealing PCR plates. 5 pk.
...l and Heat Sealing Film each provide 100% evaporat...fe and easy sample storage. In automated procedure... with standard pipette tips. The Heat Sealing Film...e in the plates. Heat Sealing Foil is removed by s...
Medicine Products: